Rep. Steve Howe

Maddy summaryHB 2670 requires video streaming services operating in Kansas to ensure commercial advertisements are not louder than the main video content they interrupt, effective July 1, 2026. It adopts the federal CALM Act standards (originally for TV broadcasts) to set volume limits for ads. The law applies specifically to internet-based streaming services targeting Kansas consumers, excluding cable operators, broadcasters, and ad-free platforms. It does not create private lawsuits for violations.

Maddy summaryHB 2677 requires all Kansas health insurance plans (excluding small employer plans and limited-benefit policies) to cover hearing aids and related services for insured children under 18 with diagnosed hearing impairments, effective January 1, 2027. The coverage includes devices, evaluations, programming, repairs, ear molds, and auditory training, with a $5,000 maximum per child over 48 months. Insurers cannot deny coverage or terminate plans based on a child's hearing impairment. This applies to all plans issued, renewed, or modified in Kansas, excluding small employer group plans and certain specialized policies.

Maddy summaryHB 2650 requires noncompete agreements between employees and employers to be reasonable and necessary for protecting the business. It makes such agreements automatically unenforceable if the business is sold or if ownership changes. This directly affects employees who might face restrictions after leaving a job, as well as employers who use noncompete clauses. The bill replaces the default enforceability of these agreements with these two specific conditions.

Maddy summaryThis bill requires prescribers to provide parents with FDA medication guides detailing psychotropic drug risks (including pediatric-specific side effects and black box warnings) before prescribing to children on Kansas' medical assistance program. It mandates the Department of Health and Environment to create a secure online reporting system for parents to document adverse reactions like seizures, mood changes, or cardiovascular symptoms. The law directly affects children under 18 enrolled in medical assistance, particularly infants (0-5 years) who frequently receive off-label prescriptions. Key mechanisms include standardized risk disclosure before prescribing and centralized digital tracking of side effects to improve safety monitoring.